ZA200710853B - Immunogenic composition - Google Patents
Immunogenic compositionInfo
- Publication number
- ZA200710853B ZA200710853B ZA200710853A ZA200710853A ZA200710853B ZA 200710853 B ZA200710853 B ZA 200710853B ZA 200710853 A ZA200710853 A ZA 200710853A ZA 200710853 A ZA200710853 A ZA 200710853A ZA 200710853 B ZA200710853 B ZA 200710853B
- Authority
- ZA
- South Africa
- Prior art keywords
- immunogenic composition
- immunogenic
- composition
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0513069.5A GB0513069D0 (en) | 2005-06-27 | 2005-06-27 | Immunogenic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200710853B true ZA200710853B (en) | 2009-04-29 |
Family
ID=34856207
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200710853A ZA200710853B (en) | 2005-06-27 | 2007-12-13 | Immunogenic composition |
| ZA200710909A ZA200710909B (en) | 2005-06-27 | 2007-12-14 | Immunogenic composition |
| ZA200711074A ZA200711074B (en) | 2005-06-27 | 2007-12-18 | Process for manufacturing vaccines |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200710909A ZA200710909B (en) | 2005-06-27 | 2007-12-14 | Immunogenic composition |
| ZA200711074A ZA200711074B (en) | 2005-06-27 | 2007-12-18 | Process for manufacturing vaccines |
Country Status (7)
| Country | Link |
|---|---|
| CN (4) | CN101208101B (en) |
| ES (1) | ES2367918T5 (en) |
| FR (1) | FR12C0060I2 (en) |
| GB (1) | GB0513069D0 (en) |
| NO (1) | NO2021022I1 (en) |
| UA (1) | UA97233C2 (en) |
| ZA (3) | ZA200710853B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE040914T4 (en) * | 2012-01-30 | 2019-05-28 | Serum Institute Of India Pvt Ltd | Immunogenic composition |
| CN104661684B (en) * | 2012-08-16 | 2018-03-20 | 辉瑞公司 | Sugared conjugation methods and composition |
| EP4309670A3 (en) * | 2016-09-02 | 2024-07-17 | Sanofi Pasteur, Inc. | Neisseria meningitidis vaccine |
| ES2847947T3 (en) * | 2016-11-25 | 2021-08-04 | Glaxosmithkline Biologicals Sa | Native VMEn-antigen conjugates and their use |
| CN109879967A (en) * | 2017-12-15 | 2019-06-14 | 苏州和锐生物科技有限公司 | A kind of preparation method and application of acetylglucosamine conjugate |
| CN110251667A (en) * | 2018-05-11 | 2019-09-20 | 武汉博沃生物科技有限公司 | A kind of immune combination preparation and its preparation method and application |
| CN115819616A (en) * | 2021-07-28 | 2023-03-21 | 江苏瑞科生物技术股份有限公司 | Gene recombination VZV fusion protein and preparation method and application thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5180815A (en) * | 1988-04-13 | 1993-01-19 | Fuji Photo Film Co., Ltd. | Modified protein for carrying hapten |
| UA76952C2 (en) * | 2000-06-29 | 2006-10-16 | Глаксосмітклайн Байолоджікалз С.А. | Polyvalent immunogenic composition, method for its preparation, use for manufacturing drug for treatment and prevention of diseases caused by haemophilus influenzae type b, method of immunization against infections caused by haemophilus influenzae type b |
| US20030068324A1 (en) * | 2001-04-06 | 2003-04-10 | Jean-Michel Fournier | Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| CN1401328A (en) * | 2002-10-18 | 2003-03-12 | 北京绿竹生物技术有限责任公司 | Epidemic meningitis polyose-protein binding vaccine |
| CN102302776B (en) * | 2003-01-30 | 2014-06-18 | 诺华疫苗和诊断有限公司 | Injectable vaccines against multiple meningococcal serogroups |
-
2005
- 2005-06-27 GB GBGB0513069.5A patent/GB0513069D0/en not_active Ceased
-
2006
- 2006-06-23 CN CN2006800230577A patent/CN101208101B/en active Active
- 2006-06-23 UA UAA200714085A patent/UA97233C2/en unknown
- 2006-06-23 ES ES06754611.9T patent/ES2367918T5/en active Active
- 2006-06-23 CN CN2006800233344A patent/CN101208103B/en active Active
- 2006-06-23 CN CN200680023149.5A patent/CN101222935B/en active Active
- 2006-06-23 CN CN2006800311786A patent/CN101247827B/en active Active
-
2007
- 2007-12-13 ZA ZA200710853A patent/ZA200710853B/en unknown
- 2007-12-14 ZA ZA200710909A patent/ZA200710909B/en unknown
- 2007-12-18 ZA ZA200711074A patent/ZA200711074B/en unknown
-
2012
- 2012-10-18 FR FR12C0060C patent/FR12C0060I2/en active Active
-
2021
- 2021-05-25 NO NO2021022C patent/NO2021022I1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA97233C2 (en) | 2012-01-25 |
| CN101208103A (en) | 2008-06-25 |
| ES2367918T3 (en) | 2011-11-10 |
| NO2021022I1 (en) | 2021-05-25 |
| CN101222935A (en) | 2008-07-16 |
| CN101208103B (en) | 2013-04-24 |
| ES2367918T5 (en) | 2014-11-21 |
| CN101208101B (en) | 2013-01-02 |
| FR12C0060I2 (en) | 2017-01-06 |
| FR12C0060I1 (en) | 2012-12-14 |
| CN101222935B (en) | 2015-07-29 |
| CN101247827B (en) | 2013-07-17 |
| ZA200710909B (en) | 2009-04-29 |
| CN101247827A (en) | 2008-08-20 |
| ZA200711074B (en) | 2009-07-29 |
| GB0513069D0 (en) | 2005-08-03 |
| CN101208101A (en) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200002I1 (en) | Immunogenic composition | |
| IL182639A0 (en) | Immunogenic composition | |
| GB0526038D0 (en) | Immunogenic composition | |
| ZA200709518B (en) | Vaccine composition | |
| ZA200710909B (en) | Immunogenic composition | |
| GB0606416D0 (en) | Immunogenic composition | |
| GB0421079D0 (en) | Immunogenic composition | |
| ZA200710854B (en) | Immunogenic composition | |
| GB0526040D0 (en) | Immunogenic composition | |
| GB0524204D0 (en) | Immunogenic composition | |
| GB0503143D0 (en) | Immunogenic composition | |
| GB0515556D0 (en) | Immunogenic composition | |
| GB0526041D0 (en) | Immunogenic composition | |
| GB0502569D0 (en) | Vaccine composition | |
| GB0421082D0 (en) | Immunogenic composition | |
| GB0421078D0 (en) | Immunogenic composition | |
| GB0421081D0 (en) | Immunogenic composition |